Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Literature DB >> 20664472

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Matthew H Kulke¹, Lowell B Anthony, David L Bushnell, Wouter W de Herder, Stanley J Goldsmith, David S Klimstra, Stephen J Marx, Janice L Pasieka, Rodney F Pommier, James C Yao, Robert T Jensen.

Abstract

Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.

Entities: Chemical Disease Gene Species

Mesh：

Year: 2010 PMID： 20664472 PMCID： PMC3100728 DOI： 10.1097/MPA.0b013e3181ebb168

Source DB: PubMed Journal: Pancreas ISSN： 0885-3177 Impact factor: 3.327

173 in total

Review 1. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

Authors: U Plöckinger; G Rindi; R Arnold; B Eriksson; E P Krenning; W W de Herder; A Goede; M Caplin; K Oberg; J C Reubi; O Nilsson; G Delle Fave; P Ruszniewski; H Ahlman; B Wiedenmann
Journal: Neuroendocrinology Date: 2005-04-18 Impact factor: 4.914

2. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups.

Authors: Steven N Hochwald; Sui Zee; Kevin C Conlon; Roberto Colleoni; Otway Louie; Murray F Brennan; David S Klimstra
Journal: J Clin Oncol Date: 2002-06-01 Impact factor: 44.544

3. Laparoscopic approach for solitary insulinoma: a multicentre study.

Authors: A Ayav; L Bresler; L Brunaud; P Boissel
Journal: Langenbecks Arch Surg Date: 2004-12-18 Impact factor: 3.445

4. Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.

Authors: Henrik Kindmark; Anders Sundin; Dan Granberg; Kristina Dunder; Britt Skogseid; Eva Tiensuu Janson; Staffan Welin; Kjell Oberg; Barbro Eriksson
Journal: Med Oncol Date: 2007 Impact factor: 3.064

Review 5. Hepatic surgery for metastases from neuroendocrine tumors.

Authors: Juan M Sarmiento; Florencia G Que
Journal: Surg Oncol Clin N Am Date: 2003-01 Impact factor: 3.495

6. Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study.

Authors: Lucio Gullo; Marina Migliori; Massimo Falconi; Paolo Pederzoli; Rossella Bettini; Riccardo Casadei; Gianfranco Delle Fave; Vito D Corleto; Claudio Ceccarelli; Donatella Santini; Paola Tomassetti
Journal: Am J Gastroenterol Date: 2003-11 Impact factor: 10.864

7. Multimodality treatment for gastric carcinoid tumor with liver metastases.

Authors: M E Caplin; H J Hodgson; A P Dhillon; R Begent; J Buscombe; R Dick; K Rolles; A K Burroughs
Journal: Am J Gastroenterol Date: 1998-10 Impact factor: 10.864

8. Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study.

Authors: James C Yao; Alexandria T Phan; David Z Chang; Robert A Wolff; Kenneth Hess; Sanjay Gupta; Carmen Jacobs; Jeannette E Mares; Andrea N Landgraf; Asif Rashid; Funda Meric-Bernstam
Journal: J Clin Oncol Date: 2008-09-10 Impact factor: 44.544

9. Cushing's syndrome in patients with the Zollinger-Ellison syndrome.

Authors: P N Maton; J D Gardner; R T Jensen
Journal: N Engl J Med Date: 1986-07-03 Impact factor: 91.245

10. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors: G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal: Virchows Arch Date: 2006-09-12 Impact factor: 4.064

162 in total

Review 1. Catching the Zebra: Clinical Pearls and Pitfalls for the Successful Diagnosis of Zollinger-Ellison Syndrome.

Authors: Aaron H Mendelson; Mark Donowitz
Journal: Dig Dis Sci Date: 2017-08-03 Impact factor: 3.199

2. Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience.

Authors: William C Chen; Richard R P Warner; Stephen C Ward; Noam Harpaz; Celia M Divino; Steven H Itzkowitz; Michelle K Kim
Journal: Dig Dis Sci Date: 2014-11-16 Impact factor: 3.199

Review 3. Contemporary management of nonfunctioning pancreatic neuroendocrine tumors.

Authors: Rebecca M Minter; Diane M Simeone
Journal: J Gastrointest Surg Date: 2011-10-19 Impact factor: 3.452

Review 4. Laparoscopic pancreatic surgery for benign and malignant disease.

Authors: Thijs de Rooij; Sjors Klompmaker; Mohammad Abu Hilal; Michael L Kendrick; Olivier R Busch; Marc G Besselink
Journal: Nat Rev Gastroenterol Hepatol Date: 2016-02-17 Impact factor: 46.802

5. Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence.

Authors: Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal: Expert Opin Pharmacother Date: 2018-05-24 Impact factor: 3.889

9. Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes.

Authors: Yugang Cheng; Hanxiang Zhan; Lei Wang; Jianwei Xu; Guangyong Zhang; Zongli Zhang; Sanyuan Hu
Journal: Front Med Date: 2016-12-23 Impact factor: 4.592

Review 10. Practical management and treatment of pancreatic neuroendocrine tumors.

Authors: Naoko Iwahashi Kondo; Yasuharu Ikeda
Journal: Gland Surg Date: 2014-11